COME HOME Treatment Pathways
Evidence Based, Physician Driven, Open Source
The COME HOME treatment pathways are developed and maintained by committees of community and academic oncologists. They are a freely available open source tool. New pathway committees meet twice monthly during pathway construction, and then quarterly to update the pathways and keep them current.
| Click Cancer Type, then use additional navigation above footer or in left margin for Stage Specific Pathways. | ||
|---|---|---|
| Cancer Type | Stage | Updated |
| Breast Cancer | DCIS Stage I-III Recurrent or Stage IV: ER or PR pos Recurrent or Stage IV ER/PR neg or endocrine refractory |
|
| Colon Cancer | Stage II Stage III Stage IV PS 0-2 Stage IV PS 3-4 |
2017 . 07 . 28 |
| Hodgkin Lymphoma | Stage IA or IIA Favorable Stage I-II Unfavorable Stage III-IV Refractory Disease |
|
| Melanoma | Stage 0-IA Resectable Stage IB or II Unresectable Stage III-IV Good PS (0-2) Unresectable Stage III-IV Poor PS (3-4) |
|
| Non-Small Cell Lung Cancer (NSCLC) | Stage IA Stage IB, IIA, IIB Stage IIIA Stage IIIB Metastatic Dis 1st line Rx Non-Squamous Metastatic Dis 1st line Rx Squamous Metastatic Dis 2nd line Rx |
2017 . 08 . 18 |
| Pancreatic Cancer | Neoadjuvant Adjuvant Locally Advanced Metastatic or Recurrent |
2017 . 09 . 15 |
| Thyroid Cancer | Metastatic Follicular, Hurthle Cell, Papillary Anaplastic Medullary |
|